| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-015898.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-015898.txt","company":"Wellgistics Health, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-015898.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_fe98d339b41a754a","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-015898.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:12:19.913136+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-015898.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-015898.txt","source_event_id":"evt_6a2b516eee42","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"598b6d5297acab98","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-10T03:04:31.796915+00:00","2026-04-09","2026-04-03","2026-01-28"],"entities":[{"asset_class":"equity","name":"Wellgistics Health, Inc.","relevance":"high","symbol":"WGRX","type":"issuer"},{"asset_class":"equity","name":"Silverback Capital Inc.","relevance":"high","symbol":"","type":"counterparty"}],"event_type":"merger_acquisition","information_gaps":["What the prior known state was before this filing (e.g., the specific terms of the settlement structure beyond what is stated here) is not provided in the signal text.","No details are provided on the alternative strategic and financing initiatives the company intends to pursue.","No information is provided on whether any other agreements or obligations exist with Silverback Capital Inc. beyond the terminated Settlement Agreement.","The filing\u2019s SEC Item 1.01/8.01 mapping is described, but no additional exhibits or financial figures are included in the provided text."],"key_facts":["Form 8-K filed for Wellgistics Health, Inc. with earliest event reported as April 3, 2026.","Item 1.01: On April 3, 2026, the Company delivered written notice to Silverback Capital Inc. terminating the Settlement Agreement dated January 28, 2026.","The Settlement Agreement contemplated issuance of shares of the Company\u2019s common stock in reliance upon Section 3(a)(10) of the Securities Act of 1933.","Prior to termination, the Company issued an aggregate of 6,866,000 shares of its common stock pursuant to the Settlement Agreement.","As a result of termination, the Company and Silverback Capital Inc. have no further obligations under the Settlement Agreement.","Item 8.01: The Company elected to terminate the previously disclosed settlement structure to pursue alternative strategic and financing initiatives.","The termination eliminates potential future dilution associated with the Settlement Agreement."],"numeric_claims":[{"label":"Shares issued prior to termination","value":"6,866,000"}],"primary_claim":"On April 3, 2026, Wellgistics Health, Inc. terminated its January 28, 2026 Settlement Agreement with Silverback Capital Inc., after issuing 6,866,000 shares under the agreement prior to termination.","relevance_score":0.72,"sentiment":"neutral","source_quality":"high","summary":"Wellgistics Health, Inc. filed a Form 8-K on April 9, 2026 (earliest event April 3, 2026) announcing termination of a January 28, 2026 Settlement Agreement with Silverback Capital Inc. The company states the termination ends further obligations and eliminates potential future dilution from the settlement structure.","topics":["SEC filing","8-K","Settlement Agreement termination","common stock issuance","potential future dilution","strategic and financing initiatives"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 Wellgistics Health, Inc. \u00b7 Filed 20260409","ticker":"WGRX","tickers":["WGRX"],"title":"WGRX filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-015898.txt"}... |